SI0970957T1 - - Google Patents

Info

Publication number
SI0970957T1
SI0970957T1 SI9930008T SI9930008T SI0970957T1 SI 0970957 T1 SI0970957 T1 SI 0970957T1 SI 9930008 T SI9930008 T SI 9930008T SI 9930008 T SI9930008 T SI 9930008T SI 0970957 T1 SI0970957 T1 SI 0970957T1
Authority
SI
Slovenia
Application number
SI9930008T
Inventor
Geo Adam
Andrea Cesura
Francois Jenck
Sabine Kolczewski
Stephan Roever
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SI0970957T1 publication Critical patent/SI0970957T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
SI9930008T 1998-06-12 1999-06-07 SI0970957T1 (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110804 1998-06-12
EP99110943A EP0970957B1 (en) 1998-06-12 1999-06-07 Diaza-spiro[3,5] nonane derivatives

Publications (1)

Publication Number Publication Date
SI0970957T1 true SI0970957T1 (id) 2001-12-31

Family

ID=8232114

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930008T SI0970957T1 (id) 1998-06-12 1999-06-07

Country Status (28)

Country Link
US (1) US6113527A (id)
EP (1) EP0970957B1 (id)
JP (1) JP3286268B2 (id)
KR (1) KR100344732B1 (id)
CN (1) CN1107066C (id)
AR (1) AR019859A1 (id)
AT (1) ATE204279T1 (id)
AU (1) AU743983B2 (id)
BR (1) BR9902651A (id)
CA (1) CA2274202A1 (id)
DE (1) DE69900220T2 (id)
DK (1) DK0970957T3 (id)
ES (1) ES2162503T3 (id)
HR (1) HRP990188A2 (id)
HU (1) HU220894B1 (id)
ID (1) ID23304A (id)
IL (1) IL130377A0 (id)
MA (1) MA26644A1 (id)
NO (1) NO312590B1 (id)
NZ (1) NZ336189A (id)
PE (1) PE20000548A1 (id)
PL (1) PL333695A1 (id)
PT (1) PT970957E (id)
SG (1) SG79259A1 (id)
SI (1) SI0970957T1 (id)
TR (1) TR199901381A3 (id)
YU (1) YU26499A (id)
ZA (1) ZA993852B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
CA2490386A1 (en) * 2001-07-02 2003-01-16 Omeros Corporation Method for producing analgesia comprising administration of an opioid receptor agonist in rotation with an opioid receptor like-1 receptor agonist
US7566728B2 (en) 2002-03-29 2009-07-28 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
JP4749715B2 (ja) 2002-07-05 2011-08-17 ターガセプト,インコーポレイテッド N−アリールジアザスピロ環式化合物、並びにその製造及び使用方法
WO2004022558A2 (en) * 2002-09-09 2004-03-18 Janssen Pharmaceutica, N.V. Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
GB0323204D0 (en) * 2003-10-03 2003-11-05 Novartis Ag Organic compounds
US20050228023A1 (en) * 2003-12-19 2005-10-13 Sri International Agonist and antagonist ligands of the nociceptin receptor
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
CN101022801A (zh) * 2004-08-20 2007-08-22 塔加西普特公司 N-芳基二氮杂螺环化合物在成瘾治疗中的用途
US20080247964A1 (en) * 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
WO2008067167A1 (en) * 2006-11-28 2008-06-05 Janssen Pharmaceutica N.V. Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
CN101679430B (zh) * 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物
KR101704226B1 (ko) 2015-06-30 2017-02-07 현대자동차주식회사 자동차의 쿼터글라스 어셈블리
TW202340202A (zh) * 2021-12-22 2023-10-16 美國加利福尼亞大學董事會 Gtp酶抑制劑及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!

Also Published As

Publication number Publication date
AR019859A1 (es) 2002-03-20
JP2000053679A (ja) 2000-02-22
ID23304A (id) 2000-04-05
EP0970957A1 (en) 2000-01-12
YU26499A (sh) 2002-09-19
IL130377A0 (en) 2000-06-01
AU3498799A (en) 1999-12-23
ES2162503T3 (es) 2001-12-16
NZ336189A (en) 2000-10-27
TR199901381A2 (xx) 2000-01-21
SG79259A1 (en) 2001-03-20
CA2274202A1 (en) 1999-12-12
TR199901381A3 (tr) 2000-01-21
KR20000006060A (ko) 2000-01-25
ATE204279T1 (de) 2001-09-15
PT970957E (pt) 2002-02-28
BR9902651A (pt) 2000-05-16
DE69900220T2 (de) 2002-05-08
NO992873L (no) 1999-12-13
HRP990188A2 (en) 2000-02-29
NO312590B1 (no) 2002-06-03
KR100344732B1 (ko) 2002-07-19
ZA993852B (en) 1999-12-13
MA26644A1 (fr) 2004-12-20
DK0970957T3 (da) 2001-12-03
HU220894B1 (en) 2002-06-29
US6113527A (en) 2000-09-05
CN1242366A (zh) 2000-01-26
PE20000548A1 (es) 2000-07-15
DE69900220D1 (de) 2001-09-20
NO992873D0 (no) 1999-06-11
PL333695A1 (en) 1999-12-20
JP3286268B2 (ja) 2002-05-27
AU743983B2 (en) 2002-02-14
EP0970957B1 (en) 2001-08-16
HU9901911D0 (en) 1999-08-30
HUP9901911A1 (hu) 2000-05-28
CN1107066C (zh) 2003-04-30

Similar Documents

Publication Publication Date Title
JP2003521259A5 (id)
JP2001517904A5 (id)
JP2001523918A5 (id)
JP2003518954A5 (id)
IN186229B (id)
IN192706B (id)
JP2534818C (id)
JP2517726Z (id)
JP2549832C (id)
IN190319B (id)
JP2539492Z (id)
JP2562803C (id)
JP2535376C (id)
JP2642621C (id)
JP2592953C (id)
JP2525273C (id)
JP2567455C (id)
JP2500162Z (id)
CN3074692S (id)
CN3086176S (id)
CN3078087S (id)
CN3077504S (id)
CN3078314S (id)
IL137948A (id)
CN3077352S (id)